DELFI Diagnostics
Genome sequencing for cancer
- B2B
- AI-native
About DELFI Diagnostics
The company specializes in using AI and whole genome sequencing to identify DNA fragmentation patterns in cancer patients' blood
Key facts
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 51–250 employees
- Headquarters
- Palo Alto, California, United States
- Founded
- 2019
- Revenue
- $25.3M – $165MTamtam estimate
- Website
- delfidiagnostics.com
DELFI Diagnostics at a glance
DELFI Diagnostics is a B2B company in the Medical and Diagnostic Laboratories industry, headquartered in Palo Alto, California, United States.
DELFI Diagnostics was founded in 2019.
DELFI Diagnostics has 51–250 employees.
DELFI Diagnostics's revenue is $25.3M – $165M (Tamtam estimate).
Selling to companies like DELFI Diagnostics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies